HEADER    HYDROLASE/HYDROLASE INHIBITOR           09-NOV-09   3KM4              
TITLE     OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN INHIBITORS      
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: RENIN;                                                     
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: ANGIOTENSINOGENASE;                                         
COMPND   5 EC: 3.4.23.15;                                                       
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: HUMAN_RENIN, REN;                                              
SOURCE   6 EXPRESSION_SYSTEM: HOMO SAPIENS;                                     
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 9606;                                       
SOURCE   8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 CELLS;                           
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1                                  
KEYWDS    RENIN, ASPARTATE PROTEASE, HYPERTENSION, RENIN EXPRESSION, RENIN      
KEYWDS   2 INHIBITOR, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES,    
KEYWDS   3 DISULFIDE BOND, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED,         
KEYWDS   4 ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX                       
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    Z.WU,B.M.MCKEEVER                                                     
REVDAT   5   06-NOV-24 3KM4    1       REMARK                                   
REVDAT   4   06-SEP-23 3KM4    1       HETSYN                                   
REVDAT   3   29-JUL-20 3KM4    1       COMPND REMARK HETNAM LINK                
REVDAT   3 2                   1       SITE   ATOM                              
REVDAT   2   19-JUN-13 3KM4    1       JRNL   VERSN                             
REVDAT   1   12-JAN-10 3KM4    0                                                
JRNL        AUTH   Z.XU,S.CACATIAN,J.YUAN,R.D.SIMPSON,L.JIA,W.ZHAO,C.M.TICE,    
JRNL        AUTH 2 P.T.FLAHERTY,J.GUO,A.ISHCHENKO,S.B.SINGH,Z.WU,B.M.MCKEEVER,  
JRNL        AUTH 3 B.B.SCOTT,Y.BUKHTIYAROV,J.BERBAUM,J.MASON,R.PANEMANGALORE,   
JRNL        AUTH 4 M.G.CAPPIELLO,R.BENTLEY,C.P.DOE,R.K.HARRISON,G.M.MCGEEHAN,   
JRNL        AUTH 5 L.W.DILLARD,J.J.BALDWIN,D.A.CLAREMON                         
JRNL        TITL   OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN        
JRNL        TITL 2 INHIBITORS.                                                  
JRNL        REF    BIOORG.MED.CHEM.LETT.         V.  20   694 2010              
JRNL        REFN                   ISSN 0960-894X                               
JRNL        PMID   19959358                                                     
JRNL        DOI    10.1016/J.BMCL.2009.11.066                                   
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.90 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.2.0019                                      
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 50.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 82.2                           
REMARK   3   NUMBER OF REFLECTIONS             : 48486                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.203                           
REMARK   3   R VALUE            (WORKING SET) : 0.200                           
REMARK   3   FREE R VALUE                     : 0.261                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.100                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 2591                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 20                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.90                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.95                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 3701                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 85.06                        
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2760                       
REMARK   3   BIN FREE R VALUE SET COUNT          : 171                          
REMARK   3   BIN FREE R VALUE                    : 0.3320                       
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 5167                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 186                                     
REMARK   3   SOLVENT ATOMS            : 462                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 28.11                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : -1.39000                                             
REMARK   3    B22 (A**2) : 2.07000                                              
REMARK   3    B33 (A**2) : -0.68000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.198         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.187         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.114         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.874         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.950                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.917                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  5489 ; 0.022 ; 0.022       
REMARK   3   BOND LENGTHS OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  7450 ; 2.119 ; 1.991       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   667 ; 8.015 ; 5.000       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   222 ;35.828 ;24.144       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   857 ;16.337 ;15.000       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    20 ;13.319 ;15.000       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   831 ; 0.145 ; 0.200       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  4103 ; 0.011 ; 0.021       
REMARK   3   GENERAL PLANES OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  2568 ; 0.229 ; 0.200       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  3757 ; 0.321 ; 0.200       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):   546 ; 0.271 ; 0.200       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):    51 ; 0.259 ; 0.200       
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):    20 ; 0.383 ; 0.200       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  3307 ; 1.231 ; 1.500       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  5345 ; 2.030 ; 2.000       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  2182 ; 3.200 ; 3.000       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  2105 ; 4.692 ; 4.500       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : MASK                                                 
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.40                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS                                                           
REMARK   4                                                                      
REMARK   4 3KM4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-09.                  
REMARK 100 THE DEPOSITION ID IS D_1000056163.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 30-MAR-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 14-ID-B                            
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9000                             
REMARK 200  MONOCHROMATOR                  : SI (111) DOUBLE-CRYSTAL            
REMARK 200                                   MONOCHROMATOR                      
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315                   
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000                           
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 62269                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.860                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 81.110                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 94.0                               
REMARK 200  DATA REDUNDANCY                : 4.700                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : 0.06600                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 19.8600                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.95                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 95.3                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.60                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : 0.31940                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 3.690                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: MOLREP                                                
REMARK 200 STARTING MODEL: PDB ENTRY 3D91                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 53.12                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH=7.0-8.0, 0.2M           
REMARK 280  (NH4)2SO4, 18-26%(W/V) PEG3350, 5MG/ML RENIN, 1MM INHIBITOR,        
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       26.91700            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       74.28400            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       48.47000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       74.28400            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       26.91700            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       48.47000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 2810 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 27140 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C                               
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     SER B   166                                                      
REMARK 465     GLU B   167                                                      
REMARK 465     ASN B   168                                                      
REMARK 465     SER B   169                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   OE1  GLN B   170     O    HOH B   466              1.89            
REMARK 500   O    HOH B   423     O    HOH B   570              2.15            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS                                      
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)               
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION                     
REMARK 500    TYR A  15   CD1   TYR A  15   CE1    -0.108                       
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    LEU A 215   CA  -  CB  -  CG  ANGL. DEV. =  20.7 DEGREES          
REMARK 500    ARG B 321   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.1 DEGREES          
REMARK 500    LEU B 338   CA  -  CB  -  CG  ANGL. DEV. =  18.0 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A   5       22.99   -142.46                                   
REMARK 500    ASP A  17       15.45     59.61                                   
REMARK 500    ASN A  75      -66.46   -126.59                                   
REMARK 500    ARG A  82       64.50   -102.72                                   
REMARK 500    THR A 312      146.67   -178.47                                   
REMARK 500    ASN B   5      -10.19   -143.89                                   
REMARK 500    SER B   8      135.16   -174.64                                   
REMARK 500    ASP B  17       13.05     58.49                                   
REMARK 500    ASN B  75      -62.80   -141.27                                   
REMARK 500    ARG B 139       18.04     49.38                                   
REMARK 500    ALA B 299       48.79    -85.02                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 VAL A  225     ASP A  226                 -148.28                    
REMARK 500 THR B    6     THR B    7                  148.46                    
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 3GW5   RELATED DB: PDB                                   
REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH A RELATED INHIBITOR                
REMARK 900 RELATED ID: 3D91   RELATED DB: PDB                                   
REMARK 900 SAME PROTEIN CO-CRYSTALLIZED WITH INHIBITOR, REMIKIREN               
DBREF  3KM4 A    4   340  UNP    P00797   RENI_HUMAN      70    406             
DBREF  3KM4 B    4   340  UNP    P00797   RENI_HUMAN      70    406             
SEQRES   1 A  337  GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET          
SEQRES   2 A  337  ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO          
SEQRES   3 A  337  PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER          
SEQRES   4 A  337  ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR          
SEQRES   5 A  337  THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP          
SEQRES   6 A  337  SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU          
SEQRES   7 A  337  ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN          
SEQRES   8 A  337  ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET          
SEQRES   9 A  337  PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET          
SEQRES  10 A  337  LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE          
SEQRES  11 A  337  GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN          
SEQRES  12 A  337  ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER          
SEQRES  13 A  337  PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU          
SEQRES  14 A  337  GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS          
SEQRES  15 A  337  TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR          
SEQRES  16 A  337  GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY          
SEQRES  17 A  337  SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU          
SEQRES  18 A  337  VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER          
SEQRES  19 A  337  SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS          
SEQRES  20 A  337  ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO          
SEQRES  21 A  337  THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU          
SEQRES  22 A  337  TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER          
SEQRES  23 A  337  TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA          
SEQRES  24 A  337  MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU          
SEQRES  25 A  337  GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP          
SEQRES  26 A  337  ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG              
SEQRES   1 B  337  GLY ASN THR THR SER SER VAL ILE LEU THR ASN TYR MET          
SEQRES   2 B  337  ASP THR GLN TYR TYR GLY GLU ILE GLY ILE GLY THR PRO          
SEQRES   3 B  337  PRO GLN THR PHE LYS VAL VAL PHE ASP THR GLY SER SER          
SEQRES   4 B  337  ASN VAL TRP VAL PRO SER SER LYS CYS SER ARG LEU TYR          
SEQRES   5 B  337  THR ALA CYS VAL TYR HIS LYS LEU PHE ASP ALA SER ASP          
SEQRES   6 B  337  SER SER SER TYR LYS HIS ASN GLY THR GLU LEU THR LEU          
SEQRES   7 B  337  ARG TYR SER THR GLY THR VAL SER GLY PHE LEU SER GLN          
SEQRES   8 B  337  ASP ILE ILE THR VAL GLY GLY ILE THR VAL THR GLN MET          
SEQRES   9 B  337  PHE GLY GLU VAL THR GLU MET PRO ALA LEU PRO PHE MET          
SEQRES  10 B  337  LEU ALA GLU PHE ASP GLY VAL VAL GLY MET GLY PHE ILE          
SEQRES  11 B  337  GLU GLN ALA ILE GLY ARG VAL THR PRO ILE PHE ASP ASN          
SEQRES  12 B  337  ILE ILE SER GLN GLY VAL LEU LYS GLU ASP VAL PHE SER          
SEQRES  13 B  337  PHE TYR TYR ASN ARG ASP SER GLU ASN SER GLN SER LEU          
SEQRES  14 B  337  GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO GLN HIS          
SEQRES  15 B  337  TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE LYS THR          
SEQRES  16 B  337  GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER VAL GLY          
SEQRES  17 B  337  SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU ALA LEU          
SEQRES  18 B  337  VAL ASP THR GLY ALA SER TYR ILE SER GLY SER THR SER          
SEQRES  19 B  337  SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA LYS LYS          
SEQRES  20 B  337  ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU GLY PRO          
SEQRES  21 B  337  THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY LYS GLU          
SEQRES  22 B  337  TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN GLU SER          
SEQRES  23 B  337  TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE HIS ALA          
SEQRES  24 B  337  MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP ALA LEU          
SEQRES  25 B  337  GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU PHE ASP          
SEQRES  26 B  337  ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA ARG              
MODRES 3KM4 ASN A   75  ASN  GLYCOSYLATION SITE                                 
MODRES 3KM4 ASN B   75  ASN  GLYCOSYLATION SITE                                 
HET    NAG  C   1      14                                                       
HET    NAG  C   2      14                                                       
HET    22X  A 400      36                                                       
HET    22X  A 341      36                                                       
HET    NAG  B 600      14                                                       
HET    22X  B 400      36                                                       
HET    22X  B 341      36                                                       
HETNAM     NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE                         
HETNAM     22X (3R)-3-[(1S)-4-(ACETYLAMINO)-1-(3-CHLOROPHENYL)-1-               
HETNAM   2 22X  HYDROXYBUTYL]-N-{(1S)-2-CYCLOHEXYL-1-[(METHYLAMINO)             
HETNAM   3 22X  METHYL]ETHYL}PIPERIDINE-1-CARBOXAMIDE                           
HETSYN     NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-           
HETSYN   2 NAG  D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-          
HETSYN   3 NAG  2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE                         
FORMUL   3  NAG    3(C8 H15 N O6)                                               
FORMUL   4  22X    4(C28 H45 CL N4 O3)                                          
FORMUL   9  HOH   *462(H2 O)                                                    
HELIX    1   1 TYR A   55  HIS A   61  1                                   7    
HELIX    2   2 ASP A   65  SER A   69  5                                   5    
HELIX    3   3 PRO A  115  MET A  120  1                                   6    
HELIX    4   4 PHE A  132  VAL A  140  5                                   9    
HELIX    5   5 PRO A  142  GLN A  150  1                                   9    
HELIX    6   6 ASP A  182  GLN A  184  5                                   3    
HELIX    7   7 SER A  235  GLY A  247  1                                  13    
HELIX    8   8 GLU A  261  LEU A  265  5                                   5    
HELIX    9   9 THR A  280  VAL A  285  1                                   6    
HELIX   10  10 GLY A  316  ARG A  321  1                                   6    
HELIX   11  11 TYR B   55  HIS B   61  1                                   7    
HELIX   12  12 ASP B   65  SER B   69  5                                   5    
HELIX   13  13 PRO B  115  MET B  120  1                                   6    
HELIX   14  14 PHE B  132  VAL B  140  5                                   9    
HELIX   15  15 PRO B  142  GLN B  150  1                                   9    
HELIX   16  16 ASP B  182  GLN B  184  5                                   3    
HELIX   17  17 SER B  235  GLY B  247  1                                  13    
HELIX   18  18 GLU B  261  LEU B  265  5                                   5    
HELIX   19  19 THR B  280  VAL B  285  1                                   6    
HELIX   20  20 GLY B  316  LYS B  322  1                                   7    
SHEET    1   A 9 LYS A  73  TYR A  83  0                                        
SHEET    2   A 9 GLY A  86  VAL A  99 -1  O  LEU A  92   N  GLY A  76           
SHEET    3   A 9 GLN A  19  ILE A  26 -1  N  GLY A  25   O  THR A  98           
SHEET    4   A 9 SER A   8  TYR A  15 -1  N  TYR A  15   O  GLN A  19           
SHEET    5   A 9 GLY A 174  LEU A 178 -1  O  LEU A 178   N  SER A   8           
SHEET    6   A 9 VAL A 157  TYR A 162 -1  N  SER A 159   O  VAL A 177           
SHEET    7   A 9 PHE A 323  ASP A 328 -1  O  PHE A 327   N  PHE A 158           
SHEET    8   A 9 ARG A 333  ALA A 339 -1  O  GLY A 335   N  GLU A 326           
SHEET    9   A 9 TYR A 186  ASN A 194 -1  N  HIS A 191   O  PHE A 336           
SHEET    1   B13 LYS A  73  TYR A  83  0                                        
SHEET    2   B13 GLY A  86  VAL A  99 -1  O  LEU A  92   N  GLY A  76           
SHEET    3   B13 ILE A 102  GLU A 113 -1  O  GLU A 110   N  PHE A  91           
SHEET    4   B13 VAL A  44  PRO A  47  1  N  VAL A  44   O  GLY A 109           
SHEET    5   B13 GLY A 126  GLY A 129 -1  O  VAL A 127   N  TRP A  45           
SHEET    6   B13 GLN A  31  ASP A  38  1  N  VAL A  36   O  VAL A 128           
SHEET    7   B13 GLN A  19  ILE A  26 -1  N  ILE A  26   O  GLN A  31           
SHEET    8   B13 SER A   8  TYR A  15 -1  N  TYR A  15   O  GLN A  19           
SHEET    9   B13 GLY A 174  LEU A 178 -1  O  LEU A 178   N  SER A   8           
SHEET   10   B13 VAL A 157  TYR A 162 -1  N  SER A 159   O  VAL A 177           
SHEET   11   B13 PHE A 323  ASP A 328 -1  O  PHE A 327   N  PHE A 158           
SHEET   12   B13 ARG A 333  ALA A 339 -1  O  GLY A 335   N  GLU A 326           
SHEET   13   B13 TYR A 186  ASN A 194 -1  N  HIS A 191   O  PHE A 336           
SHEET    1   C 4 SER A 213  LEU A 216  0                                        
SHEET    2   C 4 GLN A 202  VAL A 210 -1  N  VAL A 210   O  SER A 213           
SHEET    3   C 4 ILE A 268  LEU A 272 -1  O  HIS A 271   N  GLY A 207           
SHEET    4   C 4 LYS A 275  LEU A 279 -1  O  LEU A 279   N  ILE A 268           
SHEET    1   D 6 SER A 213  LEU A 216  0                                        
SHEET    2   D 6 GLN A 202  VAL A 210 -1  N  VAL A 210   O  SER A 213           
SHEET    3   D 6 CYS A 221  VAL A 225 -1  O  CYS A 221   N  MET A 205           
SHEET    4   D 6 TRP A 313  LEU A 315  1  O  LEU A 315   N  LEU A 224           
SHEET    5   D 6 ILE A 232  GLY A 234 -1  N  SER A 233   O  ALA A 314           
SHEET    6   D 6 ILE A 300  ALA A 302  1  O  HIS A 301   N  ILE A 232           
SHEET    1   E 3 LYS A 249  LYS A 250  0                                        
SHEET    2   E 3 TYR A 255  LYS A 258 -1  O  VAL A 256   N  LYS A 249           
SHEET    3   E 3 LEU A 295  THR A 297 -1  O  CYS A 296   N  VAL A 257           
SHEET    1   F 9 LYS B  73  TYR B  83  0                                        
SHEET    2   F 9 GLY B  86  VAL B  99 -1  O  GLY B  86   N  TYR B  83           
SHEET    3   F 9 GLN B  19  ILE B  26 -1  N  GLY B  25   O  THR B  98           
SHEET    4   F 9 SER B   8  TYR B  15 -1  N  TYR B  15   O  GLN B  19           
SHEET    5   F 9 GLY B 174  LEU B 178 -1  O  LEU B 178   N  SER B   8           
SHEET    6   F 9 VAL B 157  TYR B 162 -1  N  TYR B 161   O  GLN B 175           
SHEET    7   F 9 PHE B 323  ASP B 328 -1  O  PHE B 327   N  PHE B 158           
SHEET    8   F 9 ARG B 333  ALA B 339 -1  O  GLY B 335   N  GLU B 326           
SHEET    9   F 9 TYR B 186  ASN B 194 -1  N  HIS B 191   O  PHE B 336           
SHEET    1   G13 LYS B  73  TYR B  83  0                                        
SHEET    2   G13 GLY B  86  VAL B  99 -1  O  GLY B  86   N  TYR B  83           
SHEET    3   G13 ILE B 102  GLU B 113 -1  O  GLN B 106   N  ASP B  95           
SHEET    4   G13 VAL B  44  PRO B  47  1  N  VAL B  46   O  VAL B 111           
SHEET    5   G13 GLY B 126  GLY B 129 -1  O  VAL B 127   N  TRP B  45           
SHEET    6   G13 GLN B  31  ASP B  38  1  N  VAL B  36   O  VAL B 128           
SHEET    7   G13 GLN B  19  ILE B  26 -1  N  GLY B  22   O  VAL B  35           
SHEET    8   G13 SER B   8  TYR B  15 -1  N  TYR B  15   O  GLN B  19           
SHEET    9   G13 GLY B 174  LEU B 178 -1  O  LEU B 178   N  SER B   8           
SHEET   10   G13 VAL B 157  TYR B 162 -1  N  TYR B 161   O  GLN B 175           
SHEET   11   G13 PHE B 323  ASP B 328 -1  O  PHE B 327   N  PHE B 158           
SHEET   12   G13 ARG B 333  ALA B 339 -1  O  GLY B 335   N  GLU B 326           
SHEET   13   G13 TYR B 186  ASN B 194 -1  N  HIS B 191   O  PHE B 336           
SHEET    1   H 3 GLN B 202  MET B 205  0                                        
SHEET    2   H 3 CYS B 221  VAL B 225 -1  O  ALA B 223   N  ILE B 203           
SHEET    3   H 3 TRP B 313  LEU B 315  1  O  LEU B 315   N  LEU B 224           
SHEET    1   I 4 SER B 213  LEU B 216  0                                        
SHEET    2   I 4 VAL B 208  VAL B 210 -1  N  VAL B 208   O  LEU B 215           
SHEET    3   I 4 ILE B 268  LEU B 272 -1  O  SER B 269   N  SER B 209           
SHEET    4   I 4 LYS B 275  LEU B 279 -1  O  TYR B 277   N  PHE B 270           
SHEET    1   J 2 ILE B 232  GLY B 234  0                                        
SHEET    2   J 2 ILE B 300  ALA B 302  1  O  HIS B 301   N  ILE B 232           
SHEET    1   K 3 LYS B 249  LYS B 250  0                                        
SHEET    2   K 3 TYR B 255  LYS B 258 -1  O  VAL B 256   N  LYS B 249           
SHEET    3   K 3 LEU B 295  THR B 297 -1  O  CYS B 296   N  VAL B 257           
SSBOND   1 CYS A   51    CYS A   58                          1555   1555  2.03  
SSBOND   2 CYS A  217    CYS A  221                          1555   1555  2.09  
SSBOND   3 CYS A  259    CYS A  296                          1555   1555  2.02  
SSBOND   4 CYS B   51    CYS B   58                          1555   1555  2.02  
SSBOND   5 CYS B  217    CYS B  221                          1555   1555  2.08  
SSBOND   6 CYS B  259    CYS B  296                          1555   1555  2.10  
LINK         ND2 ASN A  75                 C1  NAG C   1     1555   1555  1.43  
LINK         ND2 ASN B  75                 C1  NAG B 600     1555   1555  1.62  
LINK         O4  NAG C   1                 C1  NAG C   2     1555   1555  1.45  
CISPEP   1 THR A   28    PRO A   29          0        -1.51                     
CISPEP   2 LEU A  117    PRO A  118          0        11.27                     
CISPEP   3 PRO A  307    PRO A  308          0         5.71                     
CISPEP   4 GLY A  310    PRO A  311          0         3.05                     
CISPEP   5 THR B   28    PRO B   29          0       -10.30                     
CISPEP   6 LEU B  117    PRO B  118          0        15.54                     
CISPEP   7 PRO B  307    PRO B  308          0        -1.45                     
CISPEP   8 GLY B  310    PRO B  311          0        -5.39                     
CRYST1   53.834   96.940  148.568  90.00  90.00  90.00 P 21 21 21    8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.018576  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.010316  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.006731        0.00000